Modern Vascular Announces Hiring of Dr. Steve Berkowitz
The company's first full-time Chief Medical Officer is a renowned expert in process improvement, healthcare reform, and ensuring superior clinical outcomes.
Lazurite, Formally Indago Announces $10 Million Financing Close
The company plans to submit its 510(k) premarket notification in late 2021 and expects to receive FDA approval to launch the product in the first half of 2022.
Otolith Labs Announces Closing of $3.3 Million in Seed Financing; Receives “Breakthrough Device” Designation from FDA for Its Prescription Treatment for Vertigo
Investors include Mark Cuban; founders of three companies acquired by large strategics; and four leading ENTs.
Lucida Medical (Cambridge University Spin-out) Joins GE Healthcare Edison™ Accelerator Programme
Lucida Medical was invited to join the Edison Accelerator programme for its pioneering work in helping identify prostate cancer and its exceptional development team led by Prof Evis Sala and Dr Antony Rix, both highly experienced in artificial intelligence, or AI, medical technology.